Coerente Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Coerente Capital Management's PFE Position: Q3 2026 in Review
Coerente Capital Management increased its Pfizer (PFE) stake by 0.26% in Q3 2026, buying an estimated $48.6K and bringing the position to 713,125 shares worth $20.3M. The position accounts for 3.56% of the portfolio, ranked #13.
Coerente Capital Management first reported a position in PFE in Q1 2021 and has held it in 23 quarters since. The position peaked at $32.5M in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Coerente Capital Management held 713,125 shares of Pfizer worth $20.3M as of Q3 2026.
- Coerente Capital Management bought 1,826 Pfizer shares in Q3 2026, an estimated $48.6K.
- Pfizer made up 3.56% of Coerente Capital Management's portfolio in Q3 2026, its #13 holding.
- Coerente Capital Management first reported a position in Pfizer in Q1 2021 and has held it in 23 quarters since.
- Coerente Capital Management's Pfizer position peaked at $32.5M in Q4 2021.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Coerente Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.